Robert A. Rissmann

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Lost and found in translation: the value of the human imiquimod model.

Lost and found in translation: the value of the human imiquimod model.

Journal: British journal of clinical pharmacology

Published: April 02, 2026

SPRAYDYE: a phase I/II randomised pilot study to assess the safety and feasibility of topically applied AKRO-6qcICG, a cathepsin-activatable fluorescent imaging agent, for real-time intraoperative resection margin assessment in breast-conserving surgery.

SPRAYDYE: a phase I/II randomised pilot study to assess the safety and feasibility of topically applied AKRO-6qcICG, a cathepsin-activatable fluorescent imaging agent, for real-time intraoperative resection margin assessment in breast-conserving surgery.

Journal: Frontiers in surgery

Published: April 01, 2026

Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial.

Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial.

Journal: Journal of the American Academy of Dermatology

Published: February 24, 2026

Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled Trials.

Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled Trials.

Journal: Clinical and translational science

Published: February 09, 2026

Remote monitoring in chronic immune-mediated inflammatory diseases: A systematic review of active and passive approaches.

Remote monitoring in chronic immune-mediated inflammatory diseases: A systematic review of active and passive approaches.

Journal: JAAD international

Published: February 03, 2026

Fibroblast-derived matrix human skin equivalents reveal distinct roles for papillary and reticular fibroblasts in human skin barrier integrity and aging.

Fibroblast-derived matrix human skin equivalents reveal distinct roles for papillary and reticular fibroblasts in human skin barrier integrity and aging.

Journal: Scientific reports

Published: November 11, 2025

S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitis.

S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitis.

Journal: British journal of clinical pharmacology

Published: November 07, 2025

Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone's impact on TLR4-mediated inflammation.

Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone's impact on TLR4-mediated inflammation.

Journal: Frontiers in immunology

Published: October 14, 2025

Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trial.

Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trial.

Journal: British journal of clinical pharmacology

Published: July 25, 2025

Clinical Validation of Imaging Biomarkers in Mycosis Fungoides.

Clinical Validation of Imaging Biomarkers in Mycosis Fungoides.

Journal: Experimental dermatology

Published: July 01, 2025

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 30, 2025

Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumab.

Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumab.

Journal: British journal of clinical pharmacology

Published: April 15, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026